会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • 신규한 헤테로사이클 유도체 및 그의 용도
    • 新的杂环衍生物及其用途
    • KR101800749B1
    • 2017-11-24
    • KR1020147010409
    • 2012-09-28
    • 주식회사 씨앤드씨신약연구소
    • 호필수윤동오한선영이원일김정숙박월성안성오김혜정
    • C07D487/14C07D471/14C07D498/14C07D519/00A61K31/4985A61K31/497A61K31/4196
    • C07D471/14C07D487/14C07D498/14C07D519/00
    • 본발명은히스타민 4 수용체의다양한기능과연관된질병을치료하는의약의제조에유용한신규한헤테로사이클화합물에관한것으로서, 상기의약은특히, 염증장애, 알러지(allergy), 통증(pain), 비강용종(nasal polyps), 비염(rhinitis), 만성부비동염(chronic sinusitis), 비충혈(nasal congestion), 코가려움증(nasal itch), 천식(asthma), 만성폐색성폐질환(chronic obstructive pulmonary disease), 류마티스관절염(rheumatoid arthritis), 아토피성피부염(atopic dermatitis), 건선(psoriasis), 습진(eczema), 소양증(prurtis), 피부가려움증(itch skin), 두드러기(urticaria), 특발성만성두드러기(idiopathic chronic urticaria), 경피증(scleroderma), 결막염(conjunctivitis), 각결막염(keratoconjunctivitis), 안염(ocular inflammation), 안구건조증(dry eye), 심장기능장애(cardiac dysfunction), 부정맥(arrhythmia), 아테롬성동맥경화증(atherosclerosis), 다발성경화증(multiple sclerosis), 염증성장 질환(대장염(colitis), 크론병(Crohn's disease), 궤양성대장염(ulcerative colitis) 포함), 염증성통증(inflammatory pain), 신경성동통(neuropathic pain), 골관절염통증(osteoarthritic pain), 갑상선자가면역질환(autoimmune thyroid disease), 면역매개(또한 1형으로서도알려진) 당뇨병, 낭창(lupus), 수술후 접착형성(post-operative adhesions), 전정장애(vestibular disorder) 그리고암(cancer) 등의치료에유용하다.
    • 本发明是有用的新型涉及一种杂环化合物,其中所述药物是被理解为包括,炎性疾病,过敏性(过敏),疼痛(疼痛),在药物的制备鼻息肉用于治疗多种与组胺4受体的疾病相关联的功能( 鼻息肉),鼻炎(鼻炎),慢性鼻窦炎(慢性鼻窦炎),鼻充血(鼻塞),鼻痒(鼻发痒),哮喘(哮喘),慢性阻塞性肺疾病(慢性阻塞性肺病),类风湿性关节炎( 类风湿性关节炎),特应性皮炎(特应性皮炎),牛皮癣(银屑病),湿疹(湿疹),瘙痒(prurtis),皮肤瘙痒(瘙痒皮肤),荨麻疹,特发性慢性荨麻疹(特发性慢性荨麻疹),硬皮病( 硬皮病),结膜炎(结膜炎),角膜结膜炎(角膜结膜炎),眼炎(眼部炎症),干眼(干眼),心脏衰竭(心功能不全),心律不齐(心律失常),动脉粥样硬化(atheroscl erosis),多发性硬化(多发性硬化症),炎性肠病(结肠炎(结肠炎),克罗恩病(节段性回肠炎),溃疡性结肠炎包括(溃疡性结肠炎)),炎性疼痛(炎症性疼痛),神经性疼痛(神经性疼痛), 骨关节炎疼痛(骨关节炎疼痛),甲状腺自身免疫病(自身免疫性甲状腺疾病),免疫介导的(也I型也如公知的)糖尿病,狼疮(狼疮),外科手术(手术后粘连)后粘连形成,前庭障碍(前庭障碍) 并且它是在癌(癌症)的治疗中是有用的。
    • 7. 发明公开
    • 헤테로사이클 유도체
    • 杂环衍生物
    • KR1020110005688A
    • 2011-01-18
    • KR1020107021818
    • 2009-03-31
    • 주식회사 씨앤드씨신약연구소
    • 안성오박찬희임준환이순옥이경준조성욱고광석한선영이원일
    • C07D498/04A61K31/5383A61P19/06
    • C07D498/04
    • PURPOSE: A heterocycle derivative used in manufacturing a medicine for treating uric acid-associated diseases is provided to ensure selectivity between organic anion transporters and high solubility and metabolic stability. CONSTITUTION: A heterocycle derivative compound has a structure of chemical formula I. A method for preparing a compound of chemical formula II or racemic body, isomer or pharmaceutically acceptable salt thereof comprises: a step of reducing a compound of chemical formula VII to obtain a compound of chemical formula VI; a step of cyclizing the compound of chemical formula VI and a compound of chemical formula V to obtain a compound of chemical formula IV; and a step of performing peptide bond of the compound of chemical formula IV and a compound of chemical formula III to obtain a compound of chemical formula II. A pharmaceutical composition contains the heterocycle derivative compound or racemic body, isomer or pharmaceutically acceptable salt thereof and pharmaceutically acceptable carrier. The pharmaceutical composition is formulated in oral administration.
    • 目的:提供用于制备用于治疗尿酸相关疾病的药物的杂环衍生物,以确保有机阴离子转运蛋白之间的选择性和高溶解度和代谢稳定性。 构成:杂环衍生物化合物具有化学式I的结构。制备化学式II化合物或外消旋体,异构体或其药学上可接受的盐的方法包括:还原化学式VII化合物以获得化合物 的化学式VI; 使化学式VI的化合物和化学式V的化合物环化的步骤,得到化学式IV的化合物; 以及化学式IV化合物和化学式III的化合物进行肽键的步骤,得到化学式II的化合物。 药物组合物含有杂环衍生物化合物或外消旋体,异构体或其药学上可接受的盐和药学上可接受的载体。 药物组合物配制成口服给药。